#VisualAbstract: Maintenance endocrine therapy plus bevacizumab after induction with paclitaxel is effective for ER+ breast cancers
Click to read this study in The Lancet Oncology.
Read MoreAug 5, 2022
Click to read this study in The Lancet Oncology.
Read MoreAug 5, 2022
1. Completion of the primary vaccination series against COVID-19 amongst individuals who had...
Read MoreAug 5, 2022
1. In this randomized controlled trial, a comprehensive telehealth intervention was linked to a...
Read MoreAug 5, 2022
Click here to read this study in NEJM.
Read MoreAug 5, 2022
1. Inhaled corticosteroid administration with systemic corticosteroid in acute asthma...
Read MoreAug 5, 2022
Click to read this study in the Journal of Clinical Oncology.
Read MoreAug 5, 2022
1. Compared to placebo, methotrexate did not significantly reduce the risk of the development of...
Read MoreAug 5, 2022
1. In this retrospective cohort study, left ventricular ejection fraction (LVEF) improvement at 30...
Read MoreAug 5, 2022
1. A higher dose of maternal milk during the critical period from very preterm birth to...
Read MoreAug 5, 2022
1. No significant differences in treatment success and rate of adverse events were detected in 8...
Read MoreAug 5, 2022
1. In this cohort study, among 158,066 individuals, offspring conceived by assisted reproductive...
Read MoreAug 5, 2022
Click to read this study in JAMA.
Read MoreAug 5, 2022
1. In this retrospective cohort study, in patients prescribed citalopram, poor/intermediate...
Read MoreAug 2, 2022
1. No significant differences in treatment success and rate of adverse events were detected in 8...
Read MoreAug 2, 2022
1. In this retrospective cohort analysis, heart failure (HF) related mortality has increased in...
Read MoreAug 1, 2022
1. Between 2011 and 2020 there was an increase in non-invasive resuscitation interventions and a...
Read MoreAug 1, 2022
1. This cohort study demonstrated that among patients with severe aortic stenosis and left...
Read MoreJul 31, 2022
1. In this secondary analysis of the DECLARE-TIMI 58 trial, among 17,160 patients, dapagliflozin...
Read MoreJul 31, 2022
1. For patients with one prior C-section, the induction of labour to delivery time was 10 hours...
Read MoreJul 31, 2022
Click to read this study in JAMA.
Read More